The Fast Facts Our reviewer committed to trying Noom long-term for 1 year
Mechanism of Action Enhances glucose-dependent insulin secretion Suppresses glucagon release Delays gastric emptying Promotes satiety via central appetite regulation Pharmacokinetics Route: Subcutaneous (once weekly) Half-life: ~1 week Metabolism: Proteolytic degradation Excretion: Urine and feces Clinical Benefits HbA1c reduction of ~11.5% Significant weight loss (515%) Proven cardiovascular protection Minimal risk of hypoglycemia when used alone Adverse Effects Common: Nausea, vomiting, diarrhea Rare: Pancreatitis, gallbladder disease Contraindicated in medullary thyroid carcinoma / MEN-2 The Bigger Picture -The transition of semaglutide from a high-cost, premium therapy to an affordable mass drug represents a paradigm shift
It was almost as good as the injectable semaglutide, though, Gokhale said
Illicit substances and certain prescription stimulants (like phentermine, another weight loss medication) should never be combined with GLP-1 compounds due to cardiovascular strain and unpredictable appetite suppression
Meng X, Hui X, Gaoxiang Q, Mingfu L, Li K, Qingfeng Z et al
doi: 10.1016/j.sxmr.2021.10.002 16 de RondeWSmitDL
